UNRESECTABLE GASTRIC ADENOCARCINOMA

Clinical trials for UNRESECTABLE GASTRIC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE GASTRIC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1

New drug combo targets Hard-to-Treat stomach cancers

Disease control Ongoing

This study is testing whether adding an experimental drug called berzosertib to a standard chemotherapy drug (irinotecan) works better than the chemotherapy alone. It is for people with advanced stomach or esophageal junction cancer that has a specific genetic change (TP53 mutati…

Matched conditions: UNRESECTABLE GASTRIC ADENOCARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

UNRESECTABLE GASTRIC ADENOCARCINOMA

Get alerted when new UNRESECTABLE GASTRIC ADENOCARCINOMA trials appear

New drug combo targets Hard-to-Treat stomach cancers